רפמיון תמיסה - Rapamune solution

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×¨×¤×××× 1 ×"× ××××××ª - Rapamune 1 mg tablets

×§×××¦× ×¤×¨××§××××××ª (ATC4)

L04AH
Mammalian target of rapamycin (mTOR) kinase inhibitors

××¨××× ×¤×¢×× (ATC5)

Sirolimus 1 MG/ML âL04AH01

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

×ª×××¡× (×¤×××), SOLUTION (ORAL)
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. It is recommended that Rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. Rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

× ×ª×× × ×¡× [ ××¦×× ]

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

×©××××© ××¡×

×ª××¨×× ××××× ××¡×

15/04/2005

××¡××¨×ª ××××× ××¡×

2. ××ª× ××ª×¨××¤× ×××¢×©× ××¤× ××¨×©× ×©× ×¨××¤× ××××× ×××××× ×××××× ×§××× ××ª ×× ×¨××¤× ××××× ××¢××¡×§ ××ª××× ×××©×ª×××ª.

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 14.10.2021

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 14.10.2021 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 31.03.2019 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 31.03.2019

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×¨×¤×××× ×ª×××¡× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	PATHEON INC. WHITBY OPERATIONS, CANADA
×©× ××¢× ××¨××©××	PFIZER PHARMACEUTICALS ISRAEL LTD
×¨××©×××	×ª××¨×× ×××©×: 2/2020. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	09/03/2022

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

↑חזרה לקטע הקודם

רפמיון תמיסה - Rapamune solution

× ×ª×× × ×¡× [ ××¦×× ]

ויקיתרופות

× ×ª×× × ×¡× [ ××¦×× ]